Citigroup notifies that stabilization measures have been undertaken in Calliditas Therapeutics' ADSs traded on The Nasdaq Global Select Market
Citigroup Global Markets Inc. ("Citigroup"), in its capacity as Joint Global Coordinator, notifies that stabilization measures have been undertaken in Calliditas Therapeutics AB's (”Calliditas” or the “Company”) American Depositary Shares ("ADSs"), traded on The Nasdaq Global Select Market.As announced by the Company in connection with the initial public offering on The Nasdaq Global Select Market, by way of a capital increase of new common shares in the form of ADSs, each representing two (2) underlying new common shares of Calliditas, (the "U.S. Offering"), and a concurrent private